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Primary cardiac lymphoma is a rare form of non-Hodgkin lymphoma that involves the heart with extension to
pericardium and great vessels. Prognosis is poor in the absence of a prompt diagnosis and adequate therapy.
Differential diagnosis includes malignant neoplasms such as angiosarcoma or metastatic carcinoma and melanoma.
Clinical manifestations may be heterogeneous. Multimodality imaging work-up represents the best method for tumor
detection and evaluation of its size and extension: echocardiography, computed tomography, magnetic resonance
imaging, and nuclear imaging are the best imaging tools. Definitive diagnosis is achieved with cytological and
histological evaluation. We report the case of a 76-year-old woman admitted to our emergency department with
symptoms of congestive heart failure. Multimodality imaging work-up showed a mediastinal bulky tumor involving
heart and pericardium. Pathology revealed a large B-cell primary cardiac lymphoma.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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A76-year-old woman with no history of cardiacdisease was admitted to our emergency
department because of symptoms of dyspnea at
rest, and episodes of chest pain occurred in recent
weeks. The patient had no complaints of fever,
sweat, or weight loss (B symptoms). She was
tachycardic and tachypneic with blood pressureof 90/60 mmHg. Blood count, liver, and renal
functions and coagulation profile test were all
within normal limits. Written consent was
obtained from the patient for each of the subse-
quent examinations.
Chest X-ray showed an enlarged heart with loss
of normal right cardiac silhouette in absence of
signs of pulmonary edema (Fig. 1). Transthoracic
echocardiography revealed pericardial effusioneCCBY-
t Assoc
Figure 1. (A) Posterior–anterior and (B) and latero–lateral chest X-ray projections showing the enlargement of the heart with loss of right cardiac
silhouette and no signs of pulmonary edema.
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2016;xxx:xxx–xxxwith an ill-defined hypoechoic mass infiltrating
the free wall of the right heart chambers.
Contrast-enhanced chest computed tomogra-
phy (CT) excluded other causes of acute chest
pain such as aortic dissection and pulmonary
embolism. The scan revealed a large infiltrating
mass localized in the pericardial space, contiguous
to the anterior myocardial walls of right atrium
and ventricle. The bulk showed extension to the
atriocaval junction, superior vena cava, and
through the atrioventricular groove involving the
base of the heart. Furthermore, there was evi-
dence of pericardial effusion that reached the
upper recesses. Relative homogeneous enhance-
ment of the mass was observed after intravenous
contrast material administration (Fig. 2).
Pericardiocentesis with drainage was per-
formed, with a substantial improvement of patient
clinical and hemodynamic conditions. A large
amount of mixed serous–hemorrhagic fluid was
collected and used for cytologic examinations:
analysis of pericardial fluid did not allow a defini-
tive diagnosis. A subsequent second contrast-
enhanced CT scan was made; unfortunately elec-
trocardiography (ECG) synchronization was not
available for this examination (Fig. 3).
During hospitalization, contrast-enhanced car-
diac magnetic resonance imaging (MRI) was per-
formed to evaluate motion relationship between
the mass and the right heart chambers, the right
atrioventricular wall involvement, the functional
impairment of the right ventricle, the left ventric-
ular function, and for a better tissue characteriza-
tion of the mass. In order to study the possible
alterations of cardiac wall kinetics, myocardium
thickness, and parietal contractility caused by
the neoplasia, retrospective ECG-triggered bal-Please cite this article in press as: Ciancarella P. et al., Multimodality ima
(2016), http://dx.doi.org/10.1016/j.jsha.2016.09.001anced turbo field echo (steady state free preces-
sion) sequences were performed. The sequences
were oriented on short and long axis (atrium–ven-
tricular and 4-chamber view), with the following
parameters: repetition time 3.8 ms; echo time
1.8 ms; flip angle 70; matrix scan 256  256; thick-
ness 8 mm; gap 0 mm; 20 cardiac phases/cycle;
and retrospective synchronization.
The examination showed impaired motion of
lateral and inferior right ventricular wall, right
atrium compression, and basal invasion of right
atrium (Figs. 4 and 5, Cine 1–3).
Precontrast black blood turbo spin echo T1, T2,
and fat saturation T2 (STIR) on the axial plane
were performed (Fig. 6); triggered short axis and
four-chamber view T2 black blood sequences were
performed to avoid heart motion artifacts (techni-
cal parameters were: repetition time 1333 ms; echo
time 100 ms; TI 290 ms; echo planar imaging factor
1; turbo factor 33; matrix scan 512  512; slice thick-
ness 8 mm; gap 0.8 mm; prospective diastolic syn-
chronization; and 1 slice per breath-hold) and
four-chamber T1 high-resolution isotropic volume
excitation and turbo spin echo T1 sequence postin-
jection of 17 mL gadolinium–diethylenetriamine
pentacetate (0.5 mmol) were performed on the
axial plane. The postgadolinium sequences
showed hyperintensity of the signal within the
mass after 140 seconds (Fig. 7).
Whole body fludeoxyglucose–positron emission
tomography/CT scan was used for the staging
procedure: the mass showed elevated
fludeoxyglucose accumulation with high Stan-
dardized Uptake Values suggesting a malignant
nature of the neoplasm with high glucose metabo-
lism (Fig. 8). The examination showed no other
localizations of disease (Fig. 9).ging evaluation of a primary cardiac lymphoma, J Saudi Heart Assoc
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Figure 2. Contrast-enhanced chest computed tomography scan; (A) coronal, (B) sagittal, and (C, D) axial views showing a large infiltrating mass
localized in the pericardial space, contiguous to the right chambers, involving also the base of the heart (empty arrows) and with extension to the
atriocaval junction and superior vena cava (arrowheads). There was also evidence of pericardial effusion that reached the upper recesses. (E, F)
Volume rendering reconstructions showing the mass (white color) and relationships with the above mentioned cardiac structures.
J Saudi Heart Assoc
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EVALUATION OF A PRIMARY CARDIAC LYMPHOMAThe patient finally underwent an open chest
biopsy through median sternotomy: detailed his-
tological examination of the tumor revealed that
it was a diffuse large B-cell lymphoma. The
patient then started combined treatment with sys-Please cite this article in press as: Ciancarella P. et al., Multimodality ima
(2016), http://dx.doi.org/10.1016/j.jsha.2016.09.001temic chemotherapy and rituximab, an anti-CD 20
monoclonal antibody (R-CHOP protocol); at pre-
sent, she is alive, asymptomatic, and keeps receiv-
ing the treatment in the absence of signs of
progression of the disease.ging evaluation of a primary cardiac lymphoma, J Saudi Heart Assoc
Figure 3. After pericardiocentesis, a contrast-enhanced computed tomography scan was performed with an improved visualization of the mass
(arrows) and its extension (arrowheads).
Figure 4. (A–F) Magnetic resonance imaging with retrospective electrocardiography-triggered balanced-turbo field echo (steady-state free
precession) sequence showing impaired diastolic dilatation of lateral and inferior right ventricular wall, right atrium compression, and basal
invasion of right atrium; despite not being hemodynamically significant, this finding is particularly evident during diastolic phase.
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Please cite this article in press as: Ciancarella P. et al., Multimodality imaging evaluation of a primary cardiac lymphoma, J Saudi Heart Assoc
(2016), http://dx.doi.org/10.1016/j.jsha.2016.09.001
Figure 6. (A, B) Magnetic resonance imaging precontrast black blood turbo spin echo T1; (C, D) T2; and (E, F), fat saturation T2 (STIR) showing
the mass (arrowheads) and its extension to vessels (solid arrow) and within cardiac structures.
Figure 5. (A) Right ventricular long axis two-chamber view with partial identification of the pulmonary outflow, (B) short axis view, and (C)
four-chamber axial view with evidence of neoplasm involving great vessels and right atrium (arrowheads), and inferior right ventricular wall
(arrows); see also Cine 1–3 for dynamic view of these findings.
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Figure 7. (A–D) Magnetic resonance imaging four chamber T1 high-resolution isotropic volume excitation and turbo spin echo T1 sequence post-
17 mL of gadolinium–diethylenetriaminepentacetate (0.5 mmol) injection. The postgadolinium sequences show mild enhancement within the
mass after 140 seconds.
C
A
SE R
EPO
RT
6 CIANCARELLA ET AL
EVALUATION OF A PRIMARY CARDIAC LYMPHOMA
J Saudi Heart Assoc
2016;xxx:xxx–xxxDiscussion
Primary lymphoma of the heart is extremely
rare: it represents only 1.3% of all primary cardiac
tumors and 0.5% of all extranodal lymphomas
[1,2]. By contrast, secondary involvement of the
heart is more common, with nearly 30% of
patients with disseminated non-Hodgkin lym-
phoma demonstrating cardiac involvement on
autopsy [3]. However, whether the lymphoma is
primary or secondary, there are no differences in
imaging findings between the two conditions.
There are no unified criteria about the definition
of primary cardiac lymphoma (PCL): generally,
PCL involves the pericardial space and myocar-
dium without any other extracardiac localizations.
PCL usually occurs in the adult population with a
male-to-female ratio of 2:1 [4]. PCL is far more
common in patients with immunodeficiency state
associated with human immunodeficiency virus
or in transplant recipients. The majority (over
70% of cases described) of PCLs are clinically
aggressive diffuse large B cell lymphomas; rare T
cell lymphomas have been reported [4–6].
Cardiac tumors are called the great mimickers
because they can present with various clinical pre-
sentations. There are no pathognomonic clinical
features of PCL and the symptoms are often non-
specific and reflects the localization and extensionPlease cite this article in press as: Ciancarella P. et al., Multimodality ima
(2016), http://dx.doi.org/10.1016/j.jsha.2016.09.001of the bulk in the heart and the mediastinum: dys-
pnea, chest pain, congestive heart failure, differ-
ent patterns of disturbance of hemodynamics
due to involvement of heart and great vessels, car-
diac tamponade due to pericardial effusion or
hemopericardium, superior vena cava syndrome,
arrhythmias such as atrial-ventricular blocks,
thrombosis, and embolism.
Integrated imaging approach is mandatory
because PCL demonstrates variable radiological
features: initial diagnosis includes chest radiogra-
phy, ECG (both transthoracic echocardiogram and
transesophageal echocardiogram), CT, MRI, and
nuclear imaging. ECG represents a quick nonin-
vasive approach to patients with dyspnea and
cardiac enlargement chest radiography: lym-
phomatous involvement of the heart appears as
hypoechoic nodular myocardial mass or ill-
defined bulk often infiltrating right cardiac cham-
bers, associated with pericardial effusion.
Although initial diagnosis of a cardiac mass
could be suspected with echocardiography in
many cases, the technical limitations of ultra-
sound impose the use of cross-sectional imaging:
CT and MRI represent the subsequent steps for
further characterization of the tumor and its
extension [7,8].
On CT imaging, PCL appears as a soft-tissue
mass iso-hypoattenuating relative to the myocar-ging evaluation of a primary cardiac lymphoma, J Saudi Heart Assoc
Figure 8. (A, B) Positron emission tomography–computed tomography scans; axial view showing elevated 18-fludeoxyglucose accumulation
within the mass with high Standardized Uptake Values suggesting a malignant nature of the neoplasm with high glucose metabolism.
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Figure 9. (A–D) Positron emission tomography–computed tomography scan; sagittal and coronal views showing no extracardiac localizations of
the disease.
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wrapping and infiltrating myocardium, peri-
cardium, great vessels, and coronary arteries. It
demonstrates heterogeneous enhancement after
intravenous contrast material administration.
When possible, ECG-gated cardiac computed
tomography, as reported in the 2010 guidelines,
is an appropriate tool to evaluate intra- and extrac-
ardiac structures; it also represents the best way to
evaluate the coronary artery and vein systems [7].
MRI is the best choice to depict accurately the
extent myocardial and pericardial infiltration.
According to the 2010 guidelines, MRI may be
used for evaluation of cardiac masses, extracardiac
structures, and involvement and characterization
of masses in the differentiation of tumors from
intracavitary mural thrombi. It also helps in dis-
criminating between benign versus malignant car-
diac masses emphasizing infiltration, invasion,
and other signs of metastasis [8].
PCL can be hypointense on T1-weighted imag-
ing and hyperintense on T2-weighted imaging,
but it can demonstrate heterogeneous signal
intensity. Contrast enhancement is frequent and
may be homogenous or heterogeneous.
Differential diagnosis is very challenging and
includes metastatic carcinomas (most commonly
of the lung), metastatic melanoma, and cardiac
sarcomas. Angiosarcoma presents often similar
localization (right heart) with pericardial effusion,
but it can be more aggressive with malignant fea-
tures such as evidence of hemorrhage and necro-
tic foci within the neoplasm. It also presents more
intense and heterogeneous contrast-enhancement
after contrast material administration on both CT
and MRI [9].
Although CT and MRI provide high-resolution
anatomic information, positron emission tomogra-
phy/CT is a good method to distinguish between
benign and malignant tumors adding information
on the metabolic activity of lesions, gaining a key-
role in the staging and follow-up of lymphomas
(especially concerning more aggressive types with
high glucose metabolism and Standardized
Uptake Value such as diffuse B-cell non-
Hodgkin lymphoma) [10].
However, final diagnosis is confirmed by peri-
cardial fluid cytology and endomyocardial or exci-
sional biopsy.Please cite this article in press as: Ciancarella P. et al., Multimodality ima
(2016), http://dx.doi.org/10.1016/j.jsha.2016.09.001Prognosis in patients with PCL remains poor
and late diagnosis seems to be the major cause
affecting the outcome [6]. Surgical resection of
PCL is often difficult and incomplete, and should
be reserved for patients with life-threatening
hemodynamic compromise [6,11]. Early systemic
treatment appears to be the only chance for cure.
Chemotherapy remains the preferred initial treat-
ment, alone or in combination with radiation ther-
apy [5,12].
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